Author | Donald A. Bergstrom, MD, PhD | OncLive

Author | Donald A. Bergstrom, MD, PhD

Articles

Dr. Bergstrom on XMT-1536 in Ovarian Cancer

October 05, 2016

Video

Donald A. Bergstrom, MD, PhD, chief medical officer, Mersana Therapeutics, discusses recent data on the new immunoconjugate, XMT-1536.

x